NorrDia High-Flux Dialyser
NorrDia H dialyser series
Our first globally introduced HD product range
High Permeability for Effective Treatment
NorrDia H dialyser series is designed for high permeability therapy, removing small and large uremic toxins to support effective hemodialysis. With high clearance rates, they enable the prescribed removal targets to be met within standard treatment times – critical for delivering high-quality dialysis care.
High Permeability with Minimal Albumin Loss
The membrane of NorrDia H dialyser series has a well-defined and controlled pore size distribution, allowing removal of middle molecules while preserving essential proteins. Maintaining blood albumin levels is important, as low albumin levels are associated with significantly higher mortality risks in dialysis patients1.
Advanced Membrane Technology for Safe and Effective Treatment
NorrDia’s membrane production allows controlled pore size distribution with a high overall porosity for optimal dialysis performance.
BPA-Free for Enhanced Patient Safety
NorrDia H dialyser series prioritises patient safety with a BPA-free polypropylene housing, reducing exposure to bisphenol A (BPA) – a substance classified by the European Commission as toxic to reproduction (Category 1B) and an endocrine disruptor of very high concern (SVHC)2.
Optimised Flow Design to Reduce Clotting and minimise blood loss
Leveraging advanced hydrodynamic research, NorrDia H dialyser series features an optimised blood inlet design that facilitates a homogeneous blood distribution in the dialyzer header.
Efficient Priming for Time and Cost Savings
NorrDia H dialyser series features an optimised dialysate flow channel design, enabling top-down priming without the need for manual intervention. This allows staff to use automatic priming functions without having to turn the dialyser, improving workflow efficiency and freeing up time for other tasks.
Comparison with Leading Brands
The performance graphic shows that the NorrDia H dialyser series matches the standards set by other top-tier brands in the market.
Data Sources:
Baxter
Revaclear Datasheet Doc. No. GBU-RC38-200001 v1.0 – December 2020
FMC
FX classix: F00006437 MT-EN (1.0 BG-pppp 08.14)
FX CorDiax: F00002818 DE (V&B – Studiodruck 09.11)
F200NRe: F50010927 Rev 07/2023
Nipro
Elisio Dialyser - brochure Doc. No. Bro-Elisio - EN - 13.Dec.18
1- Kalantar-Zadeh K, Ficociello LH, Bazzanella J, Mullon C, Anger MS. Slipping Through the Pores: Hypoalbuminemia and Albumin Loss During Hemodialysis. Int J Nephrol Renovasc Dis. 2021 Jan 20;14:11-21.
2- Commission Regulation (EU) 2024/3190 of 19 December 2024 on the use of bisphenol A (BPA) and other bisphenols and bisphenol derivatives with harmonised classification for specific hazardous properties in certain materials and articles intended to come into contact with food, amending Regulation (EU) No 10/2011 and repealing Regulation (EU) 2018/213
